>
Switch to:

NovoCure Research & Development

: $152.7 Mil (TTM As of Mar. 2021)
View and export this data going back to 2015. Start your Free Trial

This is the expense the company spent on research and development. NovoCure's research and development for the three months ended in Mar. 2021 was $45.9 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2021 was $152.7 Mil.


NovoCure Research & Development Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure Annual Data
Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Research & Development Premium Member Only Premium Member Only Premium Member Only 41.47 38.10 50.57 79.00 132.01

NovoCure Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.27 29.92 32.82 44.00 45.92

NovoCure Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2021 was 29.918 (Jun. 2020 ) + 32.818 (Sep. 2020 ) + 44.002 (Dec. 2020 ) + 45.916 (Mar. 2021 ) = $152.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NovoCure  (NAS:NVCR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


NovoCure Research & Development Related Terms


NovoCure Research & Development Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)